PDCD1 and neoplasm: Besides enhanced tumor immunogenicity, reshaped tumor immunosuppressive microenvironment, and increased CD8+ T cell recruitment, the infiltration of CD8+ T cells into tumor interiors and the enhanced tumor accumulation and penetration of PD-1 antibody are also important for the improved anti-PD-1 therapy6,9,10.